Crinetics Pharmaceuticals Inc (CRNX)vsRevolution Medicines Inc (RVMD)
CRNX
Crinetics Pharmaceuticals Inc
$32.92
-4.94%
HEALTHCARE · Cap: $3.63B
RVMD
Revolution Medicines Inc
$155.69
+4.02%
HEALTHCARE · Cap: $32.71B
Smart Verdict
WallStSmart Research — data-driven comparison
Crinetics Pharmaceuticals Inc generates 2335% more annual revenue ($18.07M vs $742,000). RVMD leads profitability with a 0.0% profit margin vs 0.0%. CRNX earns a higher WallStSmart Score of 37/100 (F).
CRNX
Hold37
out of 100
Grade: F
RVMD
Avoid24
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+71.6%
Fair Value
$167.58
Current Price
$32.92
$134.66 discount
Intrinsic value data unavailable for RVMD.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 2873.0% year-over-year
Conservative balance sheet, low leverage
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Grey zone — moderate risk
0.0% margin — thin
Weak financial health signals
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : CRNX
The strongest argument for CRNX centers on Revenue Growth, Debt/Equity, Price/Book. Revenue growth of 2873.0% demonstrates continued momentum.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : CRNX
The primary concerns for CRNX are EPS Growth, Altman Z-Score, Profit Margin.
Bear Case : RVMD
The primary concerns for RVMD are EPS Growth, Profit Margin, Operating Margin.
Key Dynamics to Monitor
CRNX profiles as a hypergrowth stock while RVMD is a value play — different risk/reward profiles.
RVMD carries more volatility with a beta of 1.41 — expect wider price swings.
CRNX is growing revenue faster at 2873.0% — sustainability is the question.
CRNX generates stronger free cash flow (-126M), providing more financial flexibility.
Bottom Line
CRNX scores higher overall (37/100 vs 24/100) and 2873.0% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Crinetics Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapies for rare endocrine diseases and endocrine-related tumors. The company is headquartered in San Diego, California.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?